Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

241.50 USD +1.33 (+0.55%)
Streaming Delayed Price Updated: 9:02 AM EST, Dec 1, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,805
Open 240.17
Bid (Size) 241.00 (2)
Ask (Size) 241.50 (3)
Prev. Close 240.17
Today's Range 240.17 - 241.91
52wk Range 223.25 - 374.99
Shares Outstanding 211,007,945
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
From GlobeNewswire News Releases
Zhang Investor Law Alerts Investors to Deadline in Securities Class Action Lawsuit Against Biogen Inc. – BIIB
From GlobeNewswire News Releases

Performance

YTD
-17.92%
-17.92%
1 Month
-3.01%
-3.01%
3 Month
-16.04%
-16.04%
6 Month
-19.89%
-19.89%
1 Year
-17.40%
-17.40%

More News

Read More
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Biogen, Inc. (BIIB) Investors
From Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
From GlobeNewswire News Releases
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Neovasc, Interface, and Biogen and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
From Business Wire News Releases
ISD Immunotech, a Novo Seeds Portfolio Company, Enters Strategic Research Collaboration for the Development of a Novel Lupus Treatment
From PR Newswire
ROSEN, A TOP RANKED LAW FIRM, Reminds Biogen Inc. Investors of Important January 12 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses in Excess of
From GlobeNewswire News Releases
A Look Into Healthcare Sector Value Stocks
Tags Earnings Benzinga Dividends
From Benzinga
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Biogen, Inc. (BIIB) Investors
From Business Wire News Releases
Sage Therapeutics Dives On $1.5 Billion Collaboration Deal With Biogen
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.